Panthera leads the way in the UK with specialist research sites for NASH and NAFLD studies

Panthera leads the way in the UK with specialist research sites for NASH and NAFLD studies.

Curebase Technology Key to metaMe Health’s FDA Clearance of Regulora

Clinical research for Regulora was successfully completed using Curebase’s decentralized clinical trial (DCT) technology and services.

Ashfield Engage, Alliance Medical and NHS partner to identify early-stage lung cancer

Alfa Chemistry Semiconductor: A Diverse Portfolio to Support Semiconductor Research

ZeOmega Adds Industry Leader to Management Team to Help Drive Payer and Provider Evolution into New Era of Value-based Care and Data-driven Quality and Experience

X-Therma Closes Oversubscribed $13M Series A Financing Led by LOREA AG

X-Therma closes an oversubscribed $13M Series A financing round led by LOREA AG. Funding will advance its breakthrough product platform rewriting biopreservation and cold chain.

Curebase Joins WCG Avoca Quality Consortium

Curebase Joins WCG Avoca Quality Consortium

Ribo-Seq Service Now Available on CD Genomics’s RNA Solutions Platforms

Epigenetics Data Analysis Service Now Available by CD Genomics’s Bioinformatics-Analysis Platform

Bioinformatics-analysis Platform is a leading open solution for data-driven innovation, which aims to discover the hidden potential in biological data and unearth new insights or predict new prospects related to life science research. CD Genomics has recently announced Epigenetics Data Analysis to move your disease research forward.

CD Genomics Fully Supports Your Microbiome Research with Comprehensive Sequencing Solutions

CD Formulation Optimizes Elemental Impurities Analysis Service

New scientific advisory Board at Qlucore

Qlucore, provider of intuitive bioinformatics software for research and precision and companion diagnostics, announces the creation of a Scientific Advisory Board (SAB), consisting of five members, chaired by Carl-Johan Ivarsson, CEO of Qlucore.

Emmes Acquires Institut Dr. Schauerte

WuXi STA Passes the First U.S. FDA Drug Product Pre-Approval Inspection at its Shanghai Waigaoqiao site

WuXi STA Forms Strategic Partnership with Coherent Biopharma

Sensyne Health and Cambridge University Hospitals NHS Foundation Trust Sign Strategic Research Agreement

Research will focus on CUH’s areas of disease expertise and specialism in cancer, cardiovascular disease and rare diseases New agreement covers 3 million patient records and brings the combined total of de-identified patient data directly accessible for medical research to 25.5 million patients

DFE Pharma researcher recognized as one of the 2021 Outstanding Early Career Scientists

Vyasa Joins NVIDIA Partner Network to Extend Availability of its GPU-Accelerated Applications Globally

Vyasa announced that it has joined the NVIDIA Partner Network (NPN) as a Solution Advisor (SA) – Consultant partner. Inclusion in the program enhances the availability of Vyasa’s deep learning applications to NVIDIA’s customers and partners.

Medinfar awarded first ever CPhI Verified Certificate

CPhI Verified certification improves supply chain transparency, providing a legal, regulatory and quality benchmark

Qlucore and Heidelberg University Hospital partnership receives 500,000 Euro from the EU for development of RNA-seq based cancer diagnostics

Qlucore is delighted to announce a joint project with Heidelberg University Hospital to develop Qlucore Diagnostics - a medical device artificial intelligence (AI) powered software for improved clinical diagnostics of lung cancer.